Results 221 to 230 of about 661,753 (260)

Kinetics of the Inhibition of Tissue Factor-Factor Vila by Tissue Factor Pathway Inhibitor

Thrombosis and Haemostasis, 1995
SummaryTissue factor-factor VIIa catalysed activation of factor X and factor IX is inhibited by the complex of tissue factor pathway inhibitor (TFPI) and factor Xa. At present, no information is available as to what extent the kinetics of complex formation between TFPI and factor Xa during factor X activation contribute to the overall rate of ...
T, Lindhout, J, Franssen, G, Willems
openaire   +2 more sources

[Tissue factor pathway inhibitors].

Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, 2002
Activation of the extrinsic pathway of blood coagulation plays the key role in the process of blood coagulation. The hemostasis is influenced by the activity of procoagulant factors and its inhibitors. In this work we summarize existing data on tissue factor pathway inhibitors: TFPI and TFPI-2.
Ewa, Sierko, Roman J, Zawadzki, Marek Z, Wojtukiewicz   +2 more
openaire   +1 more source

Tissue Factor Pathway Inhibitor (Tfpi) – An Update

Haemostasis, 2009
There is compelling experimental evidence that tissue factor pathway inhibitor (TFPI) exerts important role(s) as a natural anticoagulant. Iinmunodepletion of TFPI lowers the treshold by which tissue factor (TF) can induce disseminated intravascular coagulation.
openaire   +2 more sources

Tissue factor/tissue factor pathway inhibitor

Blood Coagulation & Fibrinolysis, 1995
J, Fareed, J L, Francis
openaire   +3 more sources

Tissue Factor Pathway Inhibitor: New Insights into an Old Inhibitor

Seminars in Thrombosis and Hemostasis, 2012
Blood coagulation in vivo is triggered by the tissue factor (TF) pathway. The major physiological regulator of this pathway is tissue factor pathway inhibitor (TFPI), a Kunitz-type inhibitor that regulates the activity of the TF-factor VIIa complex in a factor Xa-dependent manner, thus controlling the generation of thrombin and ultimately, fibrin ...
openaire   +2 more sources

The Clinical Landscape of HDAC Inhibitors

Medical Epigenetics, 2021
Arasu Ganesan
exaly  

Therapeutics and DNA Methylation Inhibitors

Medical Epigenetics, 2021
Shyamala C Navada
exaly  

Tissue Factor Pathway Inhibitor

Seminars in Thrombosis and Hemostasis, 1994
openaire   +2 more sources

Repeated Release of the Tissue Factor Pathway Inhibitor

Thrombosis and Haemostasis, 1994
R. ARIENS, E. FAIONI, P. MANNUCCI
openaire   +3 more sources

Sirtuins as NAD+-Dependent Deacetylases and Their Potential in Medical Therapy

Medical Epigenetics, 2021
Mona Dvir-Ginzberg
exaly